Evolving indications for TAVI: a PCR statement – EuroPCR 2019
Efficient TAVI in the context of expanding indications - EuroPCR 2021
TAVI: All you need to know
How should I treat asymptomatic CAD patients with an indication for TAVI? - Webinar
TAVI Innovation and the New VHD Guidelines – the Evolving Role of the Cardiac Surgeon
The implications of the latest evidence for TAVI in daily practice - EuroPCR 2019
A new era in TAVI - PCR London Valves 2017
BCIS ACI 2020: TAVI In The Treatment Of Symptomatic Aortic Stenosis — Prof Philip MacCarthy
Optimizing TAVI and expanding treatment options for patients - EuroPCR 2018
Optimising safety and efficiency of TAVI procedures - EuroPCR 2019
TAVR Indications: Good for All Risks
TAVI in bicuspid valve disease - PCR Webinar Round Table
TAVI Indications and Procedural aspect by Osman Fahim
Percutaneous edge-to-edge repair in patients with heart failure and secondary mitral regurgitation
The CoreValve™ Evolut™ PRO Transcatheter Aortic Valve (TAVR) System
Challenges with re-accessing the coronaries after TAVI - EuroPCR 2019
TAVI in Aortic Regurgitation
What is the optimal antithrombotic cocktail after TAVI?
Cardiac Surgery Review Course (Day 3): Current Indication for AVR and TAVI ( Dr. Fahd Makhdom )
Portico I sub-study shows optimised TAVI outcomes - EuroPCR 2019
